AARD
Financials
- Market Capitalization 126.71 M
- Employee 28
- Founded 2017
- CEO N/A
- Website www.aardvarktherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG01223DLB2
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3833 |  VANI Vivani Medical, Inc. - Common Stock | 1.42 USD | +1.43% | +1.43% | +10.94% | +24.56% | 128.09 M USD | ||
| 3834 |  VTVT vTv Therapeutics Inc. - Class A Common Stock | 32.36 USD | -1.34% | -3.14% | -1.94% | +57.85% | 127.95 M USD | ||
| 3838 |  CBUS Cibus, Inc. - Class A Common Stock | 1.65 USD | -1.20% | -2.37% | -14.51% | +25.00% | 126.11 M USD | ||
| 3843 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.73 USD | +2.98% | +15.33% | +42.98% | -11.73% | 125.40 M USD |
Frequently asked questions about Aardvark Therapeutics, Inc. Common Stock
What is the Aardvark Therapeutics, Inc. Common Stock stock price today?
The current price of Aardvark Therapeutics, Inc. Common Stock (AARD) is 5.79. Over the past 24 hours, the stock has changed by -12.54%. Follow the AARD chart for real-time price dynamics.
What is the stock ticker of Aardvark Therapeutics, Inc. Common Stock?
Aardvark Therapeutics, Inc. Common Stock trades under the ticker AARD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aardvark Therapeutics, Inc. Common Stock stock going up?
AARD has changed by -14.22% over the last week, +6.04% over the last month, and -54.08% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Aardvark Therapeutics, Inc. Common Stock?
Aardvark Therapeutics, Inc. Common Stock currently has a market capitalization of 126.71 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Aardvark Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Aardvark Therapeutics, Inc. Common Stock reported earnings of -0.66 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Aardvark Therapeutics, Inc. Common Stock revenue for the last quarter?
Aardvark Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Aardvark Therapeutics, Inc. Common Stock net income for the last quarter?
Aardvark Therapeutics, Inc. Common Stock reported net income of -14.39 M for the last quarter. The previous quarter showed -21.59 M, which means net income changed by +33.36%.
How many employees does Aardvark Therapeutics, Inc. Common Stock have?
As of the latest available data, Aardvark Therapeutics, Inc. Common Stock has 28 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Aardvark Therapeutics, Inc. Common Stock stock?
You can buy Aardvark Therapeutics, Inc. Common Stock (AARD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aardvark Therapeutics, Inc. Common Stock stock?
Investing in Aardvark Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AARD chart and related analysis on metatrader.com as part of your research.